The highly selective partial agonist at D1 and D5 receptors significantly improves motor function in patients recently ...

The study supports prior research that found the same thing.

People taking GLP-1 drugs can decrease fat mass while minimizing muscle loss with a few key strategies that include proper ...

A team of researchers has successfully created more effective immune cells that can fight cancer without damaging healthy ...

A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.

The rapid increase in the use of glucagon-like peptide-1 receptor agonists for weight loss, diabetes management and ...

Pfizer said it will stop development of an oral weight-loss pill after a participant taking the drug in a clinical trial ...

The researchers found that while most glucose-lowering therapies were not significantly associated with a reduction in ...

Pooled annual prevalence of GLP-1 RA use was 0.1 percent from 2018 to 2021 and increased to 0.4 percent by 2022.